Skandinaviska Enskilda Banken AB (publ) - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 146 filers reported holding AURINIA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.

Quarter-by-quarter ownership
Skandinaviska Enskilda Banken AB (publ) ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$93
-33.1%
12,000
-16.7%
0.00%0.0%
Q2 2023$139
-99.8%
14,400
+213.0%
0.00%0.0%
Q2 2020$75,0004,6000.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 111,608$2,470,0003.15%
ACT CAPITAL MANAGEMENT, LLC 180,000$3,983,0002.06%
IRONWOOD INVESTMENT MANAGEMENT LLC 167,889$3,715,0001.92%
DG Capital Management, LLC 402,200$8,901,0001.81%
NEA Management Company, LLC 5,172,683$114,471,0001.36%
KESTRA PRIVATE WEALTH SERVICES, LLC 801,100$17,728,0000.99%
Altium Capital Management LP 144,000$3,187,0000.84%
HighMark Wealth Management LLC 50,569$1,119,0000.82%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 123,500$2,724,0000.66%
SEVEN EIGHT CAPITAL, LP 288,840$6,392,0000.62%
View complete list of AURINIA PHARMACEUTICALS INC shareholders